Europe PMC

This website requires cookies, and the limited processing of your personal data in order to function. By using the site you are agreeing to this as outlined in our privacy notice and cookie policy.

Abstract 


DNA tumor viruses such as simian virus 40 (SV40) express dominant acting oncoproteins that exert their effects by associating with key cellular targets and altering the signaling pathways they govern. Thus, tumor viruses have proved to be invaluable aids in identifying proteins that participate in tumorigenesis, and in understanding the molecular basis for the transformed phenotype. The roles played by the SV40-encoded 708 amino-acid large T antigen (T antigen), and 174 amino acid small T antigen (t antigen), in transformation have been examined extensively. These studies have firmly established that large T antigen's inhibition of the p53 and Rb-family of tumor suppressors and small T antigen's action on the pp2A phosphatase, are important for SV40-induced transformation. It is not yet clear if the Rb, p53 and pp2A proteins are the only targets through which SV40 transforms cells, or whether additional targets await discovery. Finally, expression of SV40 oncoproteins in transgenic mice results in effects ranging from hyperplasia to invasive carcinoma accompanied by metastasis, depending on the tissue in which they are expressed. Thus, the consequences of SV40 action on these targets depend on the cell type being studied. The identification of additional cellular targets important for transformation, and understanding the molecular basis for the cell type-specific action of the viral T antigens are two important areas through which SV40 will continue to contribute to our understanding of cancer.

References 


Articles referenced by this article (143)

  • Ait-Si-Ali S, Polesskaya A, Filleur S, Ferreira R, Duquet A, Robin P, Vervish A, Trouche D, Cabon F and Harel-Bellan A . (2000). Oncogene, 19, 2430–2437.

  • al-Ubaidi MR, Font RL, Quiambao AB, Keener MJ, Liou GI, Overbeek PA and Baehr W . (1992a). J. Cell Biol., 119, 1681–1687.

  • al-Ubaidi MR, Hollyfield JG, Overbeek PA and Baehr W . (1992b). Proc. Natl. Acad. Sci. USA, 89, 1194–1198.



  • Arrington AS and Butel JS . (2001). Human Polyomaviruses. Khalili K and Stoner Gl (eds). Wiley-Liss, Inc.: New York, pp 461–489.

  • Asa SL, Lee YC and Drucker DJ . (1996). Virchows Arch., 427, 595–606.

  • Attwooll C, Denchi EL and Helin K . (2004). EMBO J., 23, 4709–4716.

  • Avantaggiati ML, Carbone M, Graessmann A, Nakatani Y, Howard B and Levine AS . (1996). EMBO J., 15, 2236–2248.

  • Ayabe T, Satchell DP, Wilson CL, Parks WC, Selsted ME and Ouellette AJ . (2000). Nat. Immunol., 1, 113–118.

Show 10 more references (10 of 143)

Citations & impact 


Impact metrics

Jump to Citations
Jump to Data

Citations of article over time

Alternative metrics

Altmetric item for https://www.altmetric.com/details/5103830
Altmetric
Discover the attention surrounding your research
https://www.altmetric.com/details/5103830

Smart citations by scite.ai
Smart citations by scite.ai include citation statements extracted from the full text of the citing article. The number of the statements may be higher than the number of citations provided by EuropePMC if one paper cites another multiple times or lower if scite has not yet processed some of the citing articles.
Explore citation contexts and check if this article has been supported or disputed.
https://scite.ai/reports/10.1038/sj.onc.1209046

Supporting
Mentioning
Contrasting
11
405
0

Article citations


Go to all (341) article citations

Other citations

Data 


Funding 


Funders who supported this work.

NCI NIH HHS (2)